Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.

[1]  M. Rubenfire,et al.  Diagnostic value of resting tricuspid regurgitation velocity and right ventricular ejection flow parameters for the detection of exercise induced pulmonary arterial hypertension , 2000, The International Journal of Cardiac Imaging.

[2]  C. Denton,et al.  Pulmonary hypertension in systemic sclerosis. , 2003, Rheumatic diseases clinics of North America.

[3]  E. Mahmud,et al.  Correlation of left ventricular diastolic filling characteristics with right ventricular overload and pulmonary artery pressure in chronic thromboembolic pulmonary hypertension. , 2002, Journal of the American College of Cardiology.

[4]  G. Koch,et al.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.

[5]  R. Barst,et al.  Bosentan therapy for pulmonary arterial hypertension. , 2002, The New England journal of medicine.

[6]  S. Mohr-Kahaly,et al.  Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy. , 2002, The Annals of thoracic surgery.

[7]  S. Mohr-Kahaly,et al.  Assessment of cardiac performance using Tei indices in patients undergoing pulmonary thromboendarterectomy. , 2002, The Annals of thoracic surgery.

[8]  S. Mohr-Kahaly,et al.  Quantitative assessment of right ventricular volumes in severe chronic thromboembolic pulmonary hypertension using transthoracic three-dimensional echocardiography: changes due to pulmonary thromboendarterectomy. , 2002, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[9]  Avid,et al.  BOSENTAN THERAPY FOR PULMONARY ARTERIAL HYPERTENSION , 2002 .

[10]  G. Castro.  [Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study]. , 2001, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[11]  D. Badesch,et al.  Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study , 2001, The Lancet.

[12]  C. Denton,et al.  Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. , 2001, Rheumatology.

[13]  S. Mohr-Kahaly,et al.  Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy. , 2000, Chest.

[14]  M. Fujita,et al.  Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. , 2000, American journal of respiratory and critical care medicine.

[15]  G. Koch,et al.  Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension. , 1999, The American journal of cardiology.

[16]  M. Rubenfire,et al.  Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension. , 1999, Journal of the American College of Cardiology.

[17]  M. Rubenfire,et al.  Echocardiographic features of primary pulmonary hypertension. , 1998, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  P. Sapin,et al.  Assessment of left ventricular diastolic function after single lung transplantation in patients with severe pulmonary hypertension. , 1998, Chest.

[19]  J B Seward,et al.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. , 1998, The American journal of cardiology.

[20]  L. Rubin,et al.  Primary pulmonary hypertension. , 1997, The New England journal of medicine.

[21]  G. Koch,et al.  Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension , 1997 .

[22]  B. Groves,et al.  Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. , 1997, Circulation.

[23]  A J Tajik,et al.  Doppler echocardiographic index for assessment of global right ventricular function. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[24]  A. Torbicki,et al.  More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. , 1995, The European respiratory journal.

[25]  A. Weyman.  Principles and Practice of Echocardiography , 1994 .

[26]  E. Trulock,et al.  Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation. , 1991, Journal of the American College of Cardiology.

[27]  D. Buff.  Primary pulmonary hypertension. , 1987, Annals of internal medicine.

[28]  G. Guyatt,et al.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.

[29]  M. J. Conley,et al.  An echocardiographic index for separation of right ventricular volume and pressure overload. , 1985, Journal of the American College of Cardiology.

[30]  S. Kaul,et al.  Assessment of right ventricular function using two-dimensional echocardiography. , 1984, American heart journal.

[31]  T. Furuse,et al.  Echocardiographic features of primary pulmonary hypertension. , 1976, Yonago acta medica.